SecurityXIN / Xinyuan Real Estate Co., Ltd. (98417P105)
Institutional Owners54
Institutional Shares18,485,510
Institutional Value$ 52,410,000 USD

Institutional Stock Ownership and Shareholders

Xinyuan Real Estate Co., Ltd. (NYSE:XIN) has 54 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 18,485,510 shares. Largest shareholders include TPG Group Holdings (SBS) Advisors, Inc., Renaissance Technologies LLC, Ajo, Lp, Prudential Financial Inc, Two Sigma Investments Llc, Millennium Management Llc, Susquehanna International Group, Llp, JP Morgan Chase & Co, Two Sigma Advisers, Lp, and BlackRock Inc..

Xinyuan Real Estate Co., Ltd. (NYSE:XIN) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.


File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-01-10 13F-HR SIMPLEX TRADING, LLC 28,358 24,196 -14.68 161 164 1.86
2018-02-14 13F-HR GUGGENHEIM CAPITAL LLC 19,953 63,389 217.69 113 431 281.42
2018-02-14 13F-HR STIFEL FINANCIAL CORP 39,062 254
2018-02-14 13F-HR BARCLAYS PLC Call 1,500 2,000 33.33 9 14 55.56
2018-02-14 13F-HR TWO SIGMA INVESTMENTS LLC 246,341 507,127 105.86 1,399 3,454 146.89
2018-04-18 13F-HR/A-1 FNY Managed Accounts LLC Call 205 0 -100.00 1 0 -100.00
2018-02-08 13F-HR SEI INVESTMENTS CO 9 0 -100.00 0 0
2018-02-14 13F-HR PEAK6 Investments, L.P. Put 12,000 0 -100.00 68 0 -100.00
2018-02-13 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 85,090 139,090 63.46 483 947 96.07
2018-02-13 13F-HR Renaissance Technologies LLC 1,830,900 1,713,800 -6.40 10,400 11,671 12.22
2018-02-13 13F-HR Financial Gravity Companies, Inc. 988 7
2018-02-13 13F-HR PRUDENTIAL FINANCIAL INC 555,164 762,664 37.38 3,153 5,194 64.73
2018-02-14 13F-HR BARCLAYS PLC 30,248 75,620 150.00 172 515 199.42
2018-02-09 13F-HR GROUP ONE TRADING, L.P. 52,004 86,046 65.46 295 586 98.64
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 29,400 15,700 -46.60 130 107 -17.69
2018-02-13 13F-HR Myda Advisors Llc Call 50,000 341
2018-02-09 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0 101,452 0 691
2018-02-09 13F-HR CITADEL ADVISORS LLC Call 0 10,500 0 72
2018-02-14 13F-HR BANK OF AMERICA CORP /DE/ 21,087 25,588 21.34 120 175 45.83
2018-04-06 13F-HR Eqis Capital Management, Inc. 116,495 115,786 -0.61 793 611 -22.95
2018-02-13 13F-HR Wellington Management Group LLP 41,114 280
2018-02-12 13F-HR CITIGROUP INC 7,343 7,066 -3.77 42 48 14.29
2018-03-28 13F-HR Chicago Partners Investment Group LLC 2,685 2,685 0.00 15 18 20.00
2018-01-26 13F-HR OLD POINT TRUST & FINANCIAL SERVICES N A 30,000 30,000 0.00 170 204 20.00
2018-02-14 13F-HR Cubist Systematic Strategies, LLC 10,187 0 -100.00 58 0 -100.00
2018-01-17 13F-HR Cutler Group LP Call 400 27,600 6,800.00 0 25
2018-02-14 13F-HR PEAK6 Investments, L.P. 24,442 52,813 116.07 139 360 158.99
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Call 800 137,400 17,075.00 5 936 18,620.00
2018-02-15 13F-HR JANE STREET GROUP, LLC 20,319 15,996 -21.28 115 109 -5.22
2018-02-12 13F-HR Advisors Preferred, LLC 22,526 13,944 -38.10 128 95 -25.78
2018-02-13 13F-HR/A-1 Centerstar Asset Management, Llc Call 26
2018-02-14 13F-HR LADENBURG THALMANN FINANCIAL SERVICES INC 129 0 -100.00 1 0 -100.00
2018-02-14 13F-HR ROYAL BANK OF CANADA 1,607 1,607 0.00 9 11 22.22
2018-04-09 13F-HR Founders Capital Management 28 0 -100.00 0 0
2018-02-14 13F-HR BARCLAYS PLC Put 5,300 0 -100.00 30 0 -100.00
2017-10-26 13F-HR Acrospire Investment Management LLC 502 0 -100.00 3 0 -100.00
2018-02-20 13F-HR ENVESTNET ASSET MANAGEMENT INC 916 0 -100.00 5 0 -100.00
2018-03-14 13F-HR/A-1 CREDIT SUISSE AG/ 60,212 0 -100.00 342 0 -100.00
2018-02-13 13F-HR JP Morgan Chase & Co 257,469 317,537 23.33 1,457 2,162 48.39
2018-02-14 13F-HR Invesco Ltd. 83,432 76,081 -8.81 474 518 9.28
2018-02-14 13F-HR TEACHERS ADVISORS INC 140,000 0 -100.00 795 0 -100.00
2018-01-10 13F-HR SIMPLEX TRADING, LLC Put 8 9 12.50 0 0
2018-02-09 13F-HR BlackRock Inc. 227,496 218,307 -4.04 1,292 1,486 15.02
2018-02-14 13F-HR WOLVERINE TRADING, LLC Call 19,700 0 -100.00 112 0 -100.00
2018-02-09 13F-HR CITADEL ADVISORS LLC 22,586 86,839 284.48 128 591 361.72
2018-02-13 13F-HR O'SHAUGHNESSY ASSET MANAGEMENT, LLC 25,713 0 -100.00 146 0 -100.00
2018-02-09 13F-HR Connor, Clark & Lunn Investment Management Ltd. 50,692 0 -100.00 288 0 -100.00
2018-02-14 13F-HR PICTET ASSET MANAGEMENT LTD 56,300 0 -100.00 320 0 -100.00
2018-02-14 13F-HR VANGUARD GROUP INC 175,442 182,174 3.84 997 1,241 24.47
2018-02-12 13F-HR DIMENSIONAL FUND ADVISORS LP 130,971 203,491 55.37 744 1,386 86.29
2018-02-13 13F-HR MACKENZIE FINANCIAL CORP 11,600 0 -100.00 66 0 -100.00
2018-02-14 13F-HR AJO, LP 824,280 1,001,239 21.47 4,682 6,818 45.62
2018-02-14 13F-HR Advisor Group, Inc. 132 3,745 2,737.12 1 26 2,500.00
2018-02-14 13F-HR WOLVERINE TRADING, LLC Put 20,500 36,300 77.07 116 247 112.93
2018-02-14 13F-HR WOLVERINE TRADING, LLC 37,282 31,167 -16.40 212 212 0.00
2018-02-08 13F-HR WELLS FARGO & COMPANY/MN 0 1 0 0
2018-04-12 13F-HR ACADIAN ASSET MANAGEMENT LLC 16,415 0 -100.00 112 0 -100.00
2017-11-07 13F-HR Russell Investments Group, Ltd. 2,800 0 -100.00 14 0 -100.00
2018-02-13 13F-HR Legal & General Group Plc 5,264 5,264 0.00 30 36 20.00
2018-02-14 13F-HR TWO SIGMA ADVISERS, LP 175,400 231,700 32.10 996 1,578 58.43
2018-02-09 13F-HR Tower Research Capital LLC (TRC) 54 0 -100.00 0 0
2018-02-14 13F-HR RMB Capital Management, LLC 27,000 28,006 3.73 153 191 24.84
2018-02-13 13F-HR Parallel Advisors, LLC 2,572 2,572 0.00 15 18 20.00
2018-02-14 13F-HR DEUTSCHE BANK AG\ 262,206 165,483 -36.89 1,489 1,126 -24.38
2018-02-14 13F-HR STATE STREET CORP 77,800 77,800 0.00 441 530 20.18
2018-01-17 13F-HR Cutler Group LP 2,408 9,253 284.26 13 63 384.62
2018-02-14 13F-HR Ativo Capital Management LLC 170,045 170,053 0.00 966 1,158 19.88
2018-02-09 13F-HR Virtu Financial LLC 64,518 0 -100.00 366 0 -100.00
2018-02-14 13F-HR MILLENNIUM MANAGEMENT LLC 146,028 446,929 206.06 829 3,044 267.19
2017-11-13 13F-HR Allianz Asset Management AG 31,417 0 -100.00 163 0 -100.00
2018-02-14 13F-HR PEAK6 Investments, L.P. Call 0 10,000 0 68
2018-02-08 13F-HR Advisory Services Network, LLC 4 4 0.00 0 0
2018-01-10 13F-HR SIMPLEX TRADING, LLC Call 0 35 0 5
2018-02-14 13F-HR NORTHERN TRUST CORP 42,707 34,040 -20.29 243 231 -4.94
2017-11-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 125,400 0 -100.00 650 0 -100.00
2018-02-02 13F-HR Aperio Group, LLC 85,883 76,879 -10.48 488 524 7.38
2018-03-09 SC 13D/A TPG Group Holdings (SBS) Advisors, Inc. 10,763,594
2018-02-14 13F-HR GOLDMAN SACHS GROUP INC 14,943 20,929 40.06 85 143 68.24
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 362,815 443,147 22.14 2,061 3,018 46.43
2018-02-13 13F-HR/A-1 Centerstar Asset Management, Llc 15
2018-02-14 13F-HR UBS Group AG 2,569 3,840 49.47 15 26 73.33
2018-02-14 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 65,800 113,700 72.80 374 774 106.95
2018-02-14 13F-HR TIAA CREF INVESTMENT MANAGEMENT LLC 54,700 21,800 -60.15 311 148 -52.41
2018-02-09 13F-HR PNC FINANCIAL SERVICES GROUP, INC. 100,926 30,000 -70.28 573 204 -64.40
2018-02-09 13F-HR GROUP ONE TRADING, L.P. Put 57,800 151,500 162.11 328 1,032 214.63
2018-02-02 13F-HR US BANCORP \DE\ 999 999 0.00 6 7 16.67
2018-01-17 13F-HR Cutler Group LP Put 3,200 800 -75.00 0 0
2018-02-09 13F-HR CITADEL ADVISORS LLC Put 15,900 45,800 188.05 90 312 246.67
2018-02-14 13F-HR MORGAN STANLEY 12,604 12,304 -2.38 72 84 16.67
2018-04-20 13F-HR Steward Partners Investment Advisory, Llc 300 300 0.00 2 1 -50.00

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 98417P105